HKD 2.65
(-0.38%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 9.47 Million CNY | -91.36% |
2022 | 323.12 Million CNY | 87.86% |
2021 | 172 Million CNY | 497.63% |
2020 | 28.78 Million CNY | -38.38% |
2019 | 46.7 Million CNY | -55.2% |
2018 | 104.24 Million CNY | -9.33% |
2017 | 114.96 Million CNY | 278.99% |
2016 | 30.33 Million CNY | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 24.31 Million CNY | 0.0% |
2023 Q4 | -3.54 Million CNY | 0.0% |
2023 FY | 27.93 Million CNY | -91.36% |
2023 Q2 | 13.01 Million CNY | 0.0% |
2022 Q4 | 119.58 Million CNY | 0.0% |
2022 FY | 323.12 Million CNY | 87.86% |
2022 Q2 | 203.54 Million CNY | 0.0% |
2021 Q2 | 41.6 Million CNY | 0.0% |
2021 Q4 | 130.4 Million CNY | 0.0% |
2021 FY | 172 Million CNY | 497.63% |
2020 Q2 | 9.14 Million CNY | 0.0% |
2020 Q4 | 19.63 Million CNY | 0.0% |
2020 FY | 28.78 Million CNY | -38.38% |
2019 Q4 | 22.28 Million CNY | 0.0% |
2019 FY | 46.7 Million CNY | -55.2% |
2019 Q2 | 24.42 Million CNY | 0.0% |
2018 Q2 | 80.84 Million CNY | 0.0% |
2018 FY | 104.24 Million CNY | -9.33% |
2018 Q4 | 26.33 Million CNY | 0.0% |
2017 Q2 | 25.88 Million CNY | 0.0% |
2017 Q4 | 25.52 Million CNY | 0.0% |
2017 FY | 114.96 Million CNY | 278.99% |
2017 Q1 | 25.88 Million CNY | 0.0% |
2016 FY | 30.33 Million CNY | 0.0% |
2016 Q4 | 25.88 Million CNY | 0.0% |
2016 Q2 | 7.19 Million CNY | 0.0% |
2016 Q1 | 7.19 Million CNY | 0.0% |
2015 Q4 | 7.19 Million CNY | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Wai Chun Bio-Technology Limited | 14.89 Million HKD | 36.386% |
Lee & Man Chemical Company Limited | 473.28 Million HKD | 97.998% |